Page 2 - Grna News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Grna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Grna Today - Breaking & Trending Today
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 278 public companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We will compare GreenLight Biosciences to similar businesses based on the strength of its profitability, risk, institutional ownership, dividends, earnings, analyst recommendations and valuation. Earnings and Valuation This […] ....
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) is one of 281 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it weigh in compared to its rivals? We will compare GreenLight Biosciences to similar companies based on the strength of its analyst recommendations, risk, earnings, profitability, institutional ownership, valuation and dividends. Institutional and […] ....
GreenLight Biosciences Holdings (NASDAQ:GRNA – Get Rating) shares rose 3.1% during mid-day trading on Wednesday . The company traded as high as $0.21 and last traded at $0.20. Approximately 257,201 shares changed hands during mid-day trading, a decline of 24% from the average daily volume of 336,671 shares. The stock had previously closed at $0.19. […] ....
Credit Suisse Group lowered shares of GreenLight Biosciences (NASDAQ:GRNA – Get Rating) from an outperform rating to a neutral rating in a research report released on Monday morning, The Fly reports. A number of other equities analysts have also weighed in on GRNA. Canaccord Genuity Group assumed coverage on shares of GreenLight Biosciences in a […] ....
GreenLight Biosciences (NASDAQ:GRNA – Get Rating) was downgraded by equities researchers at Credit Suisse Group from an “outperform” rating to a “neutral” rating in a note issued to investors on Monday, The Fly reports. GRNA has been the topic of a number of other reports. Canaccord Genuity Group began coverage on shares of GreenLight Biosciences […] ....